{
    "paper_id": "PMC7140187",
    "metadata": {
        "title": "Narrative review of Middle East respiratory syndrome coronavirus\n(MERS-CoV) infection: updates and implications for practice",
        "authors": [
            {
                "first": "Abbas",
                "middle": [],
                "last": "Al Mutair",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Zainab",
                "middle": [],
                "last": "Ambani",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Human coronaviruses (HCoVs) comprise six subtypes: HCoV-229E, HCoV-NL63, HCoV-OC43,\nHCoV-HKU1, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East\nrespiratory syndrome coronavirus (MERS-CoV). HCoVs are associated with a number of\nrespiratory diseases including common cold, pneumonia, and bronchitis.1,2 Investigations have identified\nfour genera of coronavirus: alpha, beta, gamma, and delta CoVs; each subgroup has\nserotypes that have been found to affect animals or humans.3",
            "cite_spans": [
                {
                    "start": 322,
                    "end": 323,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 324,
                    "end": 325,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 498,
                    "end": 499,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "HCoVs can result in life-threatening respiratory diseases, such as bronchiolitis, and\nmay also cause enteric and neurologic diseases, especially in immunocompromised\nadults, children, elderly people, and pregnant women.4 In 1960, CoV was first identified as a cause of the common cold.3\u20136 Beginning in 2002, an outbreak\nof severe acute respiratory syndrome (SARS) affected more than 1000 patients,\nprimarily in several countries of Asia, with a high mortality rate.3\u20136 The first case of MERS-CoV\ninfection in Saudi Arabia was reported on June 13, 2012 in the city of\nJeddah.3\u20137 Cases of MERS-CoV infection were\nsubsequently reported in nearly every region of Saudi Arabia; however, the most\ncommonly affected cities were Jeddah, Makkah, Riyadh, and Al-Hassa.7",
            "cite_spans": [
                {
                    "start": 219,
                    "end": 220,
                    "mention": "4",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 285,
                    "end": 286,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 286,
                    "end": 286,
                    "mention": "",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 286,
                    "end": 286,
                    "mention": "",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 287,
                    "end": 288,
                    "mention": "6",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 465,
                    "end": 466,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 466,
                    "end": 466,
                    "mention": "",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 466,
                    "end": 466,
                    "mention": "",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 467,
                    "end": 468,
                    "mention": "6",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 574,
                    "end": 575,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 575,
                    "end": 575,
                    "mention": "",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 575,
                    "end": 575,
                    "mention": "",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 575,
                    "end": 575,
                    "mention": "",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 576,
                    "end": 577,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 758,
                    "end": 759,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "The outbreak of MERS-CoV infection in Saudi Arabia resulted in many infected\nindividuals and deaths. The virus spread to nearby countries in the Middle East\nincluding Qatar, Bahrain, Kuwait, Tunisia, and Jordan.8 The outbreak also spread to Europe, North Africa, Southeast Asia, and the\nUnited States via infected travelers who had visited the Middle East.8 Many cases of infection and numerous deaths were reported among clinical\nhealth care providers who came into direct contact with infected patients in\nclinical settings.7 A total of 1227 MERS-CoV cases were recorded in Saudi Arabia from June 2012\nto December 2015; of these, 728 patients recovered and 549 died owing to MERS-CoV infection.7",
            "cite_spans": [
                {
                    "start": 211,
                    "end": 212,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 356,
                    "end": 357,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 526,
                    "end": 527,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 696,
                    "end": 697,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "The World Health Organization (WHO) stated in September 2018 that MERS-CoV infection\nhad been identified in about 27 countries, with 2260 confirmed cases and a total 803 deaths.8 Hospitals that reported outbreaks were shut down as they were unable to\naccept any more patients. The outbreak necessitated strict contact precautions to be\nimplemented in health care facilities, including isolation of infected patients and\nthe use of personal protective equipment (PPE) such as gloves, N95 respirator-type\nmasks, and gowns.5,6\nAn awareness campaign about MERS-CoV was initiated and directed by the Saudi\nMinistry of Health.9 All primary, secondary, and tertiary health care facilities, as well as\npublic health officials, participated in the campaign.9 The aim of the campaign was to educate the Saudi population and to broaden\nknowledge and prevention strategies via lectures, brochures, and social media.\nCritical patients with MERS-CoV infection often require admission to intensive care\nunits (ICU) and intubation for a long period.9 Prolonged stay in the ICU environment is associated with extreme mental and\nphysical distress, anxiety, nightmares, and respiratory distress.10,11 Prolonged\nintensive and respiratory therapy in the ICU has been reported to be associated with\nserious psychological impairment and a high prevalence of post-traumatic stress disorder.11 MERS-CoV infection events involve serious threats to one\u2019s own physical\nintegrity as well as fear, anxiety, and helplessness.10 This review aimed to update the knowledge about MERS-CoV infection to\nincrease understanding of its control and management.",
            "cite_spans": [
                {
                    "start": 177,
                    "end": 178,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 520,
                    "end": 521,
                    "mention": "5",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 522,
                    "end": 523,
                    "mention": "6",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 620,
                    "end": 621,
                    "mention": "9",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 748,
                    "end": 749,
                    "mention": "9",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1033,
                    "end": 1034,
                    "mention": "9",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1176,
                    "end": 1178,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1179,
                    "end": 1181,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1366,
                    "end": 1368,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1494,
                    "end": 1496,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "This narrative review discusses the relevant literature, including updated studies,\nand the implications for practice with respect to Middle East respiratory syndrome\ncoronavirus (MERS-CoV) infection. We performed a literature search using ProQuest,\nMEDLINE, and UpToDate. The search was restricted to articles between 2003 and 2019.\nThe search terms used were \u201cMiddle East respiratory syndrome coronavirus\u201d, \u201cMERS\nCoV\u201d, \u201cCoronavirus\u201d, \u201crespiratory illness\u201d, \u201ctransmission\u201d, and \u201cinfection control\nand management\u201d which yielded 535 results. After applying the inclusion criteria,\nthere were 268 articles remaining. After reading the article titles and abstracts,\n50 studies remained. Finally, after reading the full text, we included 22 articles\nbased on the quality of the studies.",
            "cite_spans": [],
            "section": "Literature search",
            "ref_spans": []
        },
        {
            "text": "During the MERS-CoV outbreak, cases of MERS-CoV infection were reported in 27\ncountries, among which 12 were located in the Eastern Mediterranean region.11 Although this virus spread throughout the Middle East, most confirmed cases\n(n=1882) were in Saudi Arabia with 729 deaths, comprising a fatality rate of 38.7%.11 Cases outside the Middle East most often occurred among travelers who had\nvisited the region.",
            "cite_spans": [
                {
                    "start": 153,
                    "end": 155,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 315,
                    "end": 317,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Prevalence of MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "The symptoms observed among documented cases of MERS-CoV infection comprise cough,\nfever, rhinorrhea, shortness of breath, gastrointestinal symptoms, nausea, vomiting,\nfatigue, and myalgia.7,12 In severe cases, MERS-CoV infection causes respiratory failure.\nHowever, some confirmed cases have been asymptomatic.12 Individuals aged between 50 and 59 years are at higher risk of acquiring\nprimary infection and death whereas individuals aged 30 to 39 years have a high risk\nof secondary infection.13 MERS-CoV causes more severe complications in immunocompromised patients with\na history of diabetes, renal failure, and lung diseases because these individuals\nare more prone to acquiring the infection.13",
            "cite_spans": [
                {
                    "start": 189,
                    "end": 190,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 191,
                    "end": 193,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 311,
                    "end": 313,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 495,
                    "end": 497,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 699,
                    "end": 701,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Clinical manifestation",
            "ref_spans": []
        },
        {
            "text": "Growing evidence suggests that the dromedary camel and bats serve as MERS-CoV\nreservoirs and can transmit the infection to humans.8,14 However, epidemiologically,\ncamels are more likely to be the main source of infection in humans.7,8,14 Based on investigations\nconducted in several countries, including Europe and South Africa, fecal samples of\nsome species of bats were found to have a high viral load of MERS-CoV.3,15 However, the species tested\nwere different than the existing species in Saudi Arabia, where the outbreak\noccurred.3,15 In recent studies on dromedary camels in Middle Eastern\ncountries such as Saudi Arabia, Egypt, Oman, and the United Arab Emirates, lung and\nnasal swab samples from dromedary camels have tested positive for\nMERS-Cov.16\u201321 In some studies, the percent\npositivity in tested camels reached 98% to 100%.3",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 131,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 132,
                    "end": 134,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 231,
                    "end": 232,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 233,
                    "end": 234,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 235,
                    "end": 237,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 416,
                    "end": 417,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 418,
                    "end": 420,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 535,
                    "end": 536,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 537,
                    "end": 539,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 755,
                    "end": 757,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 757,
                    "end": 757,
                    "mention": "",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 757,
                    "end": 757,
                    "mention": "",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 757,
                    "end": 757,
                    "mention": "",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 757,
                    "end": 757,
                    "mention": "",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 758,
                    "end": 760,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 838,
                    "end": 839,
                    "mention": "3",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Modes of transmission",
            "ref_spans": []
        },
        {
            "text": "MERS-CoV can be transmitted via airborne particles from one infected patient to\nanother. The main mode of human-to-human transmission is by direct contact with an\ninfected patient or infectious respiratory droplets.16 Many reported cases of MERS-CoV infection have resulted from person-to-person\ntransmission of the virus in hemodialysis units, ICUs, and other inpatient units in\ndifferent health care settings.16 Human-to-human transmission of the virus can occur directly via inhalation of\naerosol droplets transmitted through coughing or sneezing. Indirect transmission\nresults from contact with contaminated materials such as surfaces, equipment, and\ndevices. The average incubation period of MERS-CoV is about 5.2 to 12 days.8",
            "cite_spans": [
                {
                    "start": 215,
                    "end": 217,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 411,
                    "end": 413,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 730,
                    "end": 731,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Modes of transmission",
            "ref_spans": []
        },
        {
            "text": "The main control measure is adoption of contact and airborne precautions.12 It is also recommended that droplet precautions be adopted when dealing with\npatients who have acute respiratory infection.12 To prevent the spread of MERS-CoV infection, measures that must be applied\ninclude the use of PPE, gowns, and gloves as contact precautions and use of surgical\nmasks and N95 masks as droplet precautions.12 Specific additional precautions and measures must be applied during\naerosol-generating procedures such as patient airway suctioning, application of\nhigh-flow nasal oxygen, bronchoscopy, intubation, and cardiopulmonary resuscitation.\nExtra precautions needed in these situations include use of an N95 respirator or\npowered air-purifying respirator and wearing an isolation gown, goggles or face\nshield, and gloves.18 To control the disease in countries with a high prevalence of MERS-CoV\ninfection, local health authorities must enforce adherence to appropriate\nprecautions when dealing with MERS-CoV-infected patients.8",
            "cite_spans": [
                {
                    "start": 73,
                    "end": 75,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 199,
                    "end": 201,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 405,
                    "end": 407,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 821,
                    "end": 823,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1026,
                    "end": 1027,
                    "mention": "8",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Control measures",
            "ref_spans": []
        },
        {
            "text": "In many Gulf countries, animals are valuable sources of milk and meat. The trading of\ninfected animals, especially camels, is a potential source for the spread of\nMERS-CoV infection to other countries. This factor encouraged establishment of the\nOne Health Working Group, to control and prevent the transmission of MERS-CoV.22 In collaboration with the WHO and Food and Agriculture Organization of the\nUnited Nations, workshops in the application of One Health approaches were conducted\nin Qatar in 2015, with representation from Saudi Arabia, Kuwait, United Arab\nEmirates, Bahrain, Oman, Egypt, and Jordan.22 A survey was distributed to evaluate the preparedness of these countries in\ncontrolling MERS-CoV. The survey assessed several crucial elements such as\nleadership and coordination, preparedness and response planning, epidemiological\nsurveillance systems, and laboratory diagnostic capabilities.22 This survey highlighted some major challenges in these countries, such as\nlimited budgets and technical needs for surveillance, diagnosis, and research; a\nlack of skilled manpower; and denial among camel breeders about the risk of\ninfection and transmission of the disease.22 Proper adoption of the One Health model is a promising approach for better\ncontrol of MERS-CoV infection.",
            "cite_spans": [
                {
                    "start": 324,
                    "end": 326,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 607,
                    "end": 609,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 903,
                    "end": 905,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1179,
                    "end": 1181,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Control measures",
            "ref_spans": []
        },
        {
            "text": "The understanding of CoV has evolved over time, from that of a simple virus causing\nflu-like symptoms in 1960, to its identification as a more serious virus causing\nSARS in 2002 to 2003, and finally to that of a severe threat that caused the MERS\noutbreak in Saudi Arabia in 2012.7 To date, the main management strategy in MERS-CoV is administration of\nantipyretics and analgesics, maintenance of hydration, and respiratory support via\nmechanical ventilation or extracorporeal membrane oxygenation. If a patient with\nMERS-CoV has bacterial coinfection, treatment is directed toward the use of antibiotics.15 Some medications have proven to be more beneficial when started early, such\nas ribavirin and interferon alpha, which have been shown to have synergistic effects.15 Mycophenolic acid has also been shown to be efficacious, but this therapy\nrequires further supportive evidence.16 Recently, there have been attempts to develop a vaccine against MERS-CoV, but\nthis research is still in experimental stages.16",
            "cite_spans": [
                {
                    "start": 280,
                    "end": 281,
                    "mention": "7",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 605,
                    "end": 607,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 769,
                    "end": 771,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 883,
                    "end": 885,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1010,
                    "end": 1012,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Management",
            "ref_spans": []
        },
        {
            "text": "MERS-CoV infection is a potentially fatal disease that can be transmitted across\ncountries. Governments in countries with a high rate of MERS-CoV infection are urged\nto develop and implement guidelines to minimize the spread of infection. Emphasis on\nstrict application of PPE is crucial in limiting hospital-acquired infection and the\nspread of infection when handling patients with suspected MERS-CoV infection. It is\nalso important to raise awareness among travelers to regions affected by MERS-CoV\nabout the signs and symptoms of the disease and to urge individuals to report any of\nthese signs and symptoms so as to receive proper and timely care.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Coronavirus 229E-related\npneumonia in immunocompromised patients.",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pene",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Merlat",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vabret",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Clin Infect Dis",
            "volume": "37",
            "issn": "",
            "pages": "929-932",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "System effectiveness of\ndetection, brief intervention and refer to treatment for the people with\npost-traumatic emotional distress by MERS: a case report of community-based\nproactive intervention in South Korea",
            "authors": [
                {
                    "first": "MK",
                    "middle": [],
                    "last": "Yoon",
                    "suffix": ""
                },
                {
                    "first": "SY",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "HS",
                    "middle": [],
                    "last": "Ko",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int J Ment\nHealth Syst",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Post-ICU psychological\nmorbidity in very long ICU stay patients with ARDS and\ndelirium.",
            "authors": [
                {
                    "first": "FR",
                    "middle": [],
                    "last": "Bashar",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vahedian-Azimi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hajiesmaeili",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Crit Care",
            "volume": "43",
            "issn": "",
            "pages": "88-94",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Surveillance of the Middle\nEast respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare\nworkers after contact with confirmed MERS patients: incidence and risk\nfactors of MERS-CoV seropositivity.",
            "authors": [
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Jeong",
                    "suffix": ""
                },
                {
                    "first": "ES",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "SY",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Clin Microbiol Infect",
            "volume": "22",
            "issn": "",
            "pages": "880-886",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [],
            "year": 2018,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin\nand animal reservoir",
            "authors": [
                {
                    "first": "HA",
                    "middle": [],
                    "last": "Mohd",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Al-Tawfiq",
                    "suffix": ""
                },
                {
                    "first": "ZA.",
                    "middle": [],
                    "last": "Memish",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Virol J",
            "volume": "13",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Evaluation of candidate\nvaccine approaches for MERS-CoV",
            "authors": [
                {
                    "first": "PD",
                    "middle": [],
                    "last": "Kwong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Solomon",
                    "suffix": ""
                },
                {
                    "first": "DJ",
                    "middle": [],
                    "last": "Mollura",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nat Commun",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/ncomms8712"
                ]
            }
        },
        "BIBREF7": {
            "title": "Hospital outbreak of Middle\nEast Respiratory Syndrome Coronavirus.",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Assiri",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "McGeer",
                    "suffix": ""
                },
                {
                    "first": "TM",
                    "middle": [],
                    "last": "Perl",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "N Engl J Med",
            "volume": "36",
            "issn": "",
            "pages": "407-416",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "MERS coronavirus in\ndromedary camel herd, Saudi Arabia",
            "authors": [
                {
                    "first": "MG",
                    "middle": [],
                    "last": "Hemida",
                    "suffix": ""
                },
                {
                    "first": "DK",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "LL",
                    "middle": [],
                    "last": "Poon",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Emerg Infect\nDis",
            "volume": "20",
            "issn": "",
            "pages": "1231-1234",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Dromedary camels and the\ntransmission of Middle East respiratory syndrome coronavirus\n(MERS\u2010CoV).",
            "authors": [
                {
                    "first": "MG",
                    "middle": [],
                    "last": "Hemida",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Elmoslemany",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Al\u2010Hizab",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Transbound Emerg Dis",
            "volume": "64",
            "issn": "",
            "pages": "344-353",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Seroepidemiology for MERS\ncoronavirus using microneutralisation and pseudoparticle virus\nneutralisation assays reveal a high prevalence of antibody in dromedary\ncamels in Egypt, June 2013.",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Perera",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Gomaa",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Euro Surveill",
            "volume": "18",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Human coronaviruses: a\nreview of virus\u2013host interactions",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tam",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Diseases",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Middle East respiratory syndrome coronavirus (MERS-CoV) in\ndromedary camels, Oman, 2013",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nowotny",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Kolodziejek",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Euro Surveill",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Middle East respiratory\nsyndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria,\n2015",
            "authors": [
                {
                    "first": "DK",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "JO",
                    "middle": [],
                    "last": "Oladipo",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Perera",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Euro Surveill",
            "volume": "20",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Survey on implementation of\none health approach for MERS-CoV preparedness and control in Gulf\nCooperation Council and Middle East Countries",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Farag",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nour",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "El Idrissi",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Emerg\nInfect Dis",
            "volume": "25",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "The history and epidemiology of Middle East respiratory syndrome\ncorona virus",
            "authors": [
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Al-Osail",
                    "suffix": ""
                },
                {
                    "first": "MJ.",
                    "middle": [],
                    "last": "Al-Wazzah",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Multidiscip Respir Med",
            "volume": "12",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Zaki",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Isolation of a novel\ncoronavirus from a man with pneumonia in Saudi Arabia.",
            "authors": [
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Zaki",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "van Boheemen",
                    "suffix": ""
                },
                {
                    "first": "TM",
                    "middle": [],
                    "last": "Bestebroer",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "NEngl J Med",
            "volume": "367",
            "issn": "",
            "pages": "1814-1820",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "First cases of Middle East\nrespiratory syndrome Coronavirus (MERS-CoV) infections in France,\ninvestigations and implications for the prevention of human-to-human\ntransmission",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mailles",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Blanckaert",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chaud",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Euro Surveill",
            "volume": "18",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Contact investigation of a\ncase of human novel coronavirus infection treated in a German hospital,\nOctober-November 2012",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Buchholz",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "M\u00fcller",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nitsche",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Euro Surveill",
            "volume": "18",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Middle East respiratory syndrome coronavirus (MERS-CoV):\nprevention in travelers.",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pavli",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tsiodras",
                    "suffix": ""
                },
                {
                    "first": "HC.",
                    "middle": [],
                    "last": "Maltezou",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Travel Med Infect Dis",
            "volume": "12",
            "issn": "",
            "pages": "602-608",
            "other_ids": {
                "DOI": [
                    "10.1016/j.tmaid.2014.10.006"
                ]
            }
        },
        "BIBREF21": {
            "title": "Healthcare workers emotions,\nperceived stressors and coping strategies during MERS-CoV\noutbreak",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Khalid",
                    "suffix": ""
                },
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Khalid",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Qabajah",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Clin Med Res",
            "volume": "14",
            "issn": "",
            "pages": "7-14",
            "other_ids": {
                "DOI": []
            }
        }
    }
}